Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BlackRock, Inc.
BlackRock Reports Third Quarter Diluted EPS of $1.62
November 9th, 2008
BlackRock, Inc. (NYSE:BLK) reported net income for the 2008 third quarter of $218 million, a decrease of 15%, or $1.62 per diluted share, a decrease of $0.32 compared to the third quarter of 2007. Net income for the first nine months of 2008 totaled $733 million, or $5.49 per diluted share, an increase of 9% compared to the first nine months of 2007. Diluted earnings per share for the third quarter 2008 included a $0.58 non-operating loss, net of non-controlling interests, due to adverse market effects on co-investments and seed investments, compared to non-operating gains, net of non-controlling interests, in the third quarter of 2007 of $0.23. The third quarter 2008 reported operating...
Source: Pharma Investments, Ventures & Law Weekly (2008-11-09)
|
